BioSpace News Archive

Ideal Image® is kicking off its first-ever Lucky Days Pop-Up Sale, a 10-day promotion to celebrate St. Patrick’s Day, with offers on MedSpa services

Procedure time reduction in lithotripsy and benefits in BPH treatments

Vycellix™, Inc. today announced that the Company, founded by leading medical researchers at Sweden’s world renowned Karolinska Institutet, will present at the Innate Killer Summit 2019 to be held in San Diego, March 20-21.

Mother Dirt, the microbiome company creating skincare products containing a live culture of bacteria, announced today its first-ever pop-up shop at SHOWFIELDS in New York, a retail concept that invites visitors to discover and engage with the brands of tomorrow.

Mile High Labs International Inc. unveiled today the Mile High Monster, their latest innovation in industrial-scale CBD extraction technology.

Centric Medical, the Foot & Ankle division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology announced today the first clinical cases of SATURN External Fixation System.

We’re in an unprecedented era of innovation in medical devices with advances in materials science that have led to technological breakthroughs such as the 3D printing of medical devices, continuous glucose monitoring patches for diabetes and miniaturized brain implants to treat epilepsy and Parkinson’s disease.

Crystal Clinic Orthopaedic Center will break ground on its much-anticipated flagship orthopedic hospital this Spring of 2019.

NervGen Pharma Corp., a Vancouver-based company founded to develop regenerative-medicine technology licensed from Case Western Reserve University, raised about $7.5 million ($10 million in Canadian dollars) from an initial public offering.

Enigma Biomedical Group (EBG) today announced an exclusive license agreement with Merck, known as MSD outside the US and Canada, for the global development and commercialization of MK-6884, an early stage investigational imaging agent developed by Merck for use in Positron Emission Tomography (PET) scans to measure cholinergic tone change in vivo.